These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 24734893

  • 1. Serum concentrations of HE4 change little during in vitro fertilization.
    Hallamaa M, Huhtinen K, Suvitie P, Perheentupa A.
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):640-6. PubMed ID: 24734893
    [Abstract] [Full Text] [Related]

  • 2. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ, Yang HY, Lin JJ, Chen X, Ye BL.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [Abstract] [Full Text] [Related]

  • 3. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY, Choi YS, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH.
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [Abstract] [Full Text] [Related]

  • 4. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
    La Marca A, Pati M, Giulini S, Levratti P, Caretto S, Volpe A.
    Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM, Engage Investigators.
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [Abstract] [Full Text] [Related]

  • 6. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S, Fedorcsak P, Abyholm T, Storeng R, Ertzeid G, Oldereid N, Omland A, Tanbo T.
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [Abstract] [Full Text] [Related]

  • 7. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA, Gómez-Palomares JL, Ricciarelli E, Hernández ER.
    Fertil Steril; 2010 Mar 01; 93(4):1215-9. PubMed ID: 19200978
    [Abstract] [Full Text] [Related]

  • 8. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles.
    Urbancsek J, Hauzman EE, Murber A, Lagarde AR, Rabe T, Papp Z, Strowitzki T.
    Gynecol Endocrinol; 2005 Jul 01; 21(1):38-44. PubMed ID: 16048800
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study.
    Gholami H, Vicari E, Molis M, La Vignera S, Papaleo E, Cappiello F.
    Eur Rev Med Pharmacol Sci; 2010 Feb 01; 14(2):97-102. PubMed ID: 20329567
    [Abstract] [Full Text] [Related]

  • 10. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
    Foong SC, Abbott DH, Lesnick TG, Session DR, Walker DL, Dumesic DA.
    Fertil Steril; 2005 May 01; 83(5):1377-83. PubMed ID: 15866572
    [Abstract] [Full Text] [Related]

  • 11. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M.
    BJOG; 2004 Nov 01; 111(11):1248-53. PubMed ID: 15521870
    [Abstract] [Full Text] [Related]

  • 12. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT, Linh NK, Tuong HM, Wong PC, Howles CM.
    Reprod Biomed Online; 2013 Oct 01; 27(4):390-9. PubMed ID: 23953069
    [Abstract] [Full Text] [Related]

  • 13. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov 01; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S, Chen XN, Qiao J, Liu P, Li R, Chen GA, Ma CH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr 01; 47(4):245-9. PubMed ID: 22781108
    [Abstract] [Full Text] [Related]

  • 15. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells.
    Cai J, Lou HY, Dong MY, Lu XE, Zhu YM, Gao HJ, Huang HF.
    Fertil Steril; 2007 Jun 01; 87(6):1350-6. PubMed ID: 17296182
    [Abstract] [Full Text] [Related]

  • 16. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI.
    Lazaros L, Hatzi E, Xita N, Takenaka A, Sofikitis N, Zikopoulos K, Georgiou I.
    J Reprod Med; 2013 Jun 01; 58(9-10):395-401. PubMed ID: 24050028
    [Abstract] [Full Text] [Related]

  • 17. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
    Smitz J, Andersen AN, Devroey P, Arce JC, MERIT Group.
    Hum Reprod; 2007 Mar 01; 22(3):676-87. PubMed ID: 17110397
    [Abstract] [Full Text] [Related]

  • 18. Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women.
    Hallamaa M, Suvitie P, Huhtinen K, Matomäki J, Poutanen M, Perheentupa A.
    Gynecol Oncol; 2012 Jun 01; 125(3):667-72. PubMed ID: 22426487
    [Abstract] [Full Text] [Related]

  • 19. Serum and follicular fluid leptin during in vitro fertilization: relationship among leptin increase, body fat mass, and reduced ovarian response.
    Bützow TL, Moilanen JM, Lehtovirta M, Tuomi T, Hovatta O, Siegberg R, Nilsson CG, Apter D.
    J Clin Endocrinol Metab; 1999 Sep 01; 84(9):3135-9. PubMed ID: 10487676
    [Abstract] [Full Text] [Related]

  • 20. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Apr 01; 20(4):915-22. PubMed ID: 15665015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.